Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...

After spending years tracing the origin and migration pattern of an unusual type of immune cell in mice, researchers have ...

Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease.

Subhash Verma, Ph.D., professor of microbiology and immunology, and his research team at the University of Nevada, Reno ...

Research from the University of Virginia School of Medicine has revealed crucial new insights into the immune systems of ...

AbbVie snagged yet another spot among April’s highest TV ad spenders, as its Vraylar jumped two spots to eighth place with a ...

In pediatric patients, lower Child Opportunity Index scores at birth were linked to elevated incidence rates of asthma with ...

BHVN's Troriluzole awaits pivotal FDA approval in 2025, backed by $600M funding. Explore its diverse pipeline and promising ...

Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting disease.

T he millions of people who suffer from seasonal allergies each year are too familiar with symptoms like sneezing, wheezing, ...

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease.

A wave of biosimilar approvals, aggressive pricing strategies, and a regulatory sea change are setting the stage for ...